Cancer researchers at the University of California, San Francisco, have discovered a new therapy that shows promise in treating a wide range of cancer types.
The therapy, which uses a combination of two existing drugs, is able to kill cancer cells while leaving healthy cells unharmed. In laboratory tests, the treatment was effective against cancer cells from breast, lung, pancreatic, and ovarian cancer, as well as melanoma.
Importantly, the treatment was also effective against cancer cells that had become resistant to other treatments, such as chemotherapy.
The researchers are now working on clinical trials to test the effectiveness of the therapy in humans. If successful, the treatment could provide a much-needed new option for patients with advanced cancer who have few treatment options remaining.
The study was published in the journal Nature Medicine.
Cancer is a leading cause of death worldwide, with approximately 18 million new cases and 9.6 million deaths in 2018 alone. Despite significant progress in recent years, existing treatments are often harsh and not always effective, leaving patients and their families desperate for new, more targeted therapies.
Now, researchers from the University of Pennsylvania have developed a new cancer therapy that is much more specific and less toxic than existing treatments. The therapy, which is based on CRISPR-Cas9 technology, works by targeting cancer cells and destroying them while leaving healthy cells unharmed.
In a recent study, the therapy was found to be effective in treating various types of cancer in mice, including breast, skin, and ovarian cancer. The researchers are now planning to conduct clinical trials in humans to see if the therapy is safe and effective.
This new therapy offers hope to the millions of people who are fighting cancer. If the clinical trials are successful, it could change the way we treat cancer forever.